Advanced Biomedical Technologies Inc. 10-K


 


Exhibit
10.1 


Loan
Agreement


 


TTD/ABMT/L1510-01  


 


	Lender:	TITAN
                                         TECHNOLOGY DEVELOPMENT LIMITED
	Address:	1903
                                         HING YIP COMMERCIAL CENTRE, 272 DES VOEUX ROAD CENTRAL, HONG KONG.
	 	(Hong
                                         Kong Company Registration No.: 718332)



  


		Borrower:	ADVANCED
BIOMEDICAL TECHNOLOGIES, INC.






	Address:	350
                                         FIFTH AVE., 59TH FLOOR, NEW YORK, NY 10118
	 	USA
                                         (Incorporated in the State of Nevada, USA)



   


Borrower
is the controlling shareholder of Shenzhen Changhua Biomedical Engineering Co. Ltd., approved by Shenzhen Bureau of Trade and
Industry’s permit, February 25, 2008 (2008) No. 0539 and Guangdong Shenzhen Joint Venture Permit (2008) No. 0008. Shenzhen
Changhua Biomedical Engineering Co., Ltd. is a company engaged in research and development and production of biodegradable medical
materials. Lender is a major shareholder of Borrower.


 


	1)	Loan:
	 	 
	 	Lender
agrees to advance to Borrower’s subsidiary Shenzhen Changhua Biomedical Engineering Co., Ltd. (Changhua) the total amount
of USD480,000 - (Four Hundred and Eighty Thousand US dollars).
	 	 
	 	Borrower
accepts that Lender may send the total amount in several advances using different financial institutions, associated companies
or individuals that is appointed by Lender.



  


		2)	Use
of Proceed: For Changhua’s R&D, Clinical Trial, GMP Facilities Upgrading and Operation Expenses.



 


		3)	Interest
Rate: Annual interest rate is seven percent (7%).



 


		4)	Loan
Repayment period: 12 months



 


	5)	Repayment:
	 	 
	 	Debt
maturity: after 12 months, Borrower will repay Lender the total amount of loan plus interest.
	 	 
	 	Outstanding
loan: after 6 months, Lender may demand the return of part of the loan plus interest occurred.



  


	6)	Repayment
Methods and Repayment Source
	 	 
	 	Repayment
Methods: cash or securities;
	 	 
	 	Repayment
Source: banks and securities firms.



 



    	 



    	 



    



   


	7)	Warranty:
	 	 
	 	Borrower
and its subsidiary guarantee that the loan will be used for the purposes stipulated in this agreement and the fund may not be
used for other purposes or illegal activities;  

                                                      Borrower will return the loan within the terms stipulated in this agreement; 

                                                       
Borrower
and its subsidiary agree to accept the supervision of Lender on the use of proceed provided under this agreement.




 


	8)	Miscellaneous
	 	 
	 	This
                                         Agreement may not be amended or modified except by a writing executed by each of the
                                         parties. Neither party shall assign (including the engagement of subcontractors) any
                                         of its rights or obligations under this Agreement without the prior written consent of
                                         the other party. The provisions of this Agreement, including without limitation the obligation
                                         to make loan and interest repayments, shall be binding on Borrower, its Parent Company,
                                         its successors and assigns. All terms of this Agreement, which by their nature extend
                                         beyond its termination, shall remain in effect until fulfilled, and shall apply to the
                                         respective successors and assigns of the parties; 
	 	 
	 	This
Agreement, including all controversies arising from or relating to performance under this Agreement, shall be governed by and
construed in accordance with the laws of Hong Kong, China. Venue for any action or dispute arising from or relating to this Agreement
shall conclusively lie in the Courts located in Hong Kong, China. Each party hereby waives any objection that it may have based
upon lack of personal jurisdiction, improper venue or forum non conveniens.



 


	 	 	 
	Lender: TITAN
TECHNOLOGY DEVELOPMENT LIMITED






	Signature:	/s/ Chi Fung YU	 






	Name and Title:	Chi Fung YU, Chairman	 



 


		 	 
	Borrower: ADVANCED
                                         BIOMEDICAL TECHNOLOGIES, INC.
	Signature:	/s/
Hui Wang	 





	Name and Title:	Hui Wang, Director and Chief Executive Officer 	 
	 
	Date: October
31, 2015